☆ 4.2 Article

The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem

TRANSPLANTATION AND CELLULAR THERAPY (2022)

Related references

Note: Only part of the references are listed.

Article Cell Biology

The accelerated aging phenotype: The role of race and social determinants of health on aging

Nicole Noren Hooten et al.

Summary: Understanding the biology and mechanisms of aging is crucial for developing interventions to prevent and treat age-related diseases. Health disparities can contribute to an accelerated aging phenotype, particularly in marginalized populations. The interaction of biological, psychosocial, socioeconomic and environmental factors may result in an increased susceptibility to oxidative stress and premature accumulation of DNA damage, leading to health disparities and premature mortality.

AGEING RESEARCH REVIEWS (2022)

Add to Collection

Article Health Care Sciences & Services

Systemic And Structural Racism: Definitions, Examples, Health Damages, And Approaches To Dismantling

Paula A. Braveman et al.

Summary: Racism can manifest in both conscious and unconscious ways, and it can be seen as both a systemic and structural issue. Systemic and structural racism is deeply embedded within systems, laws, policies, and practices that perpetuate unfair treatment and oppression of people of color, leading to negative health consequences. Addressing these forms of racism requires coordinated efforts across multiple sectors and locations, with the crucial first step being the recognition of their existence.

HEALTH AFFAIRS (2022)

Add to Collection

Article Hematology

Therapy Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access

Nausheen Ahmed et al.

Summary: CAR T cell therapy has shown disparities in racial/ethnic distribution, socioeconomic strata, and insurance coverage, with African Americans and Hispanics being underrepresented. Patients living farther from treatment centers tend to be from higher socioeconomic backgrounds. Low enrollment of minorities in clinical trials contributes to these disparities, indicating a need for strategies to address the root causes.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

Add to Collection

Article Hematology

Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis

Jason Dehn et al.

Summary: This study analyzed data from US donor searches in 2016 and identified factors such as race/ethnic group and adult unrelated donor search prognosis score associated with patients proceeding to transplant within 6 months. White patients were more likely to receive a transplant, and the prognosis score was strongly associated with transplantation in various patient populations.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Add to Collection

Article Oncology

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

Sanghee Hong et al.

Summary: This study analyzed the impact of community health status on allogeneic HCT outcomes using data from CHRR and CIBMTR, finding that patients residing in counties with a worse community health status have inferior survival due to increased risk of NRM after allogeneic HCT. There was no significant association between the community health status of the transplant center location and allogeneic HCT outcomes.

CANCER (2021)

Add to Collection

Article Hematology

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

Kira Bona et al.

Summary: This study aimed to investigate the impact of neighborhood poverty on outcomes of pediatric allogeneic HCT recipients, revealing that in malignant diseases, neighborhood poverty increased the risk of transplantation-related mortality but did not affect overall survival or other HCT outcomes; for nonmalignant diseases, neighborhood poverty had no association with HCT outcomes. Additionally, children with Medicaid insurance experienced worse overall survival and increased transplantation-related mortality in malignant diseases.

BLOOD (2021)

Add to Collection

Article Education, Scientific Disciplines

Increasing access to allotransplants in the United States: the impact of race, geog ra phy, and socioeconomics

Sanghee Hong et al.

Summary: Allogeneic hematopoietic cell transplantation (HCT) is significantly influenced by racial, socioeconomic, and geographic disparities, with minority populations facing challenges in finding optimal donors and accessing transplant centers. Research has focused on social determinants of health affecting access to HCT, particularly race/ethnicity and socioeconomic status, with a pressing need for interventions to address these disparities. Additional studies are needed to explore opportunities for future research and policy changes to mitigate these disparities.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)

Add to Collection

Article Hematology

Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease

Tatenda G. Mupfudze et al.

Summary: In the United States, patients with Sickle Cell Disease (SCD) undergoing allogeneic hematopoietic cell transplantation (alloHCT) on Medicaid have lower event-free survival (EFS) and higher incidence of graft failure compared to those with private insurance. There were no significant differences between the two groups in terms of overall survival (OS) and acute and chronic graft-versus-host disease (GVHD).

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Add to Collection

Article Hematology

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy

Abraham S. Kanate et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Add to Collection

Article Hematology

Caregivers' Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer Center

Kenneth R. Meehan et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Add to Collection

Review Hematology

Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age

Colin Flannelly et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Add to Collection

Article Oncology

Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice

Jaime M. Preussler et al.

SUPPORTIVE CARE IN CANCER (2019)

Add to Collection

Article Hematology

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis

Kristjan Paulson et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Add to Collection

Review Hematology

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

Shannon R. McCurdy et al.

BLOOD (2019)

Add to Collection

Article Oncology

Variation in Medicaid Coverage for Hematopoietic Cell Transplantation

Jaime M. Preussler et al.

JOURNAL OF ONCOLOGY PRACTICE (2014)

Add to Collection

Article Oncology

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Benjamin D. Smith et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.